NCT00002663 2023-02-13Biological Therapy in Treating Patients at High-Risk or With Lymphoma, Lymphoproliferative Disease, or MalignanciesAtara BiotherapeuticsPhase 1/2 Completed58 enrolled 18 charts
NCT00406809 2021-08-02A Study of ABT-263 in Subjects With Relapsed or Refractory Lymphoid MalignanciesAbbViePhase 1/2 Completed81 enrolled
NCT00611208 2016-11-29A-dmDT390-bisFv(UCHT1) Immunotoxin Therapy for Patients With Cutaneous T-Cell Lymphoma (CTCL)Angimmune LLCPhase 2 Completed32 enrolled
NCT00293488 2016-06-23SL-11047 in Treating Patients With Relapsed or Refractory LymphomaProgen PharmaceuticalsPhase 1 Completed20 enrolled
NCT01748721 2016-01-08MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or LymphomaMorphotekPhase 1 Completed27 enrolled
NCT00538850 2014-03-05Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainINSYS Therapeutics IncPhase 3 Completed130 enrolled 9 charts